Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/66/2e/de/662ede70-c619-89ac-12af-65eca2efed05/mza_11590254275384415089.jpg/600x600bb.jpg
FDA Drug Information Updates
ReachMD
20 episodes
7 months ago
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
Show more...
Science
Medicine
RSS
All content for FDA Drug Information Updates is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
Show more...
Science
Medicine
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/66/2e/de/662ede70-c619-89ac-12af-65eca2efed05/mza_11590254275384415089.jpg/600x600bb.jpg
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
FDA Drug Information Updates
7 years ago
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry

The FDA has made strides in improving transparency and data access, and has implemented tools to allow the pharmaceutical industry and the public to transform raw data into usable information. One of these tools is called the FDA Adverse Event Reporting System (FAERS) Public Dashboard. In this episode, the architects of the FAERS Public Dashboard – Deputy Director of the Regulatory Science Staff Suranjan De, and Acting Team Lead in Regulatory Science Information Sanjay Sahoo—both of CDER’s Office of Surveillance and Epidemiology, highlight their work with this new online tool.

FDA Drug Information Updates
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.